Placebo is 0.9% (w/v) NaCl for injection and is to be provided by sites., IVX-A12
D8610C00001
Phase 3 small_molecule active
Quick answer
Placebo is 0.9% (w/v) NaCl for injection and is to be provided by sites., IVX-A12 for Respiratory Syncytial Virus and Human Metapneumovirus is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Respiratory Syncytial Virus and Human Metapneumovirus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active